Abnormal activation of mitogen-activated protein kinase cascades contributes to chronic inflammation and immune dysregulation in SLE, and may play a role in the neuroinflammatory processes underlying NPSLE.[7] In addition, mesenchymal stem cells have emerged as a promising approach in the field of regenerative medicine and immunotherapy. The gene discussed is WNK2; the disease is systemic lupus erythematosus.